All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ0706 | Anti-CXCL11 (CBXC-2347) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-2347 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ0707 | Anti-CXCL11 (CBXC-1341) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-1341 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ0708 | Anti-CXCL11 (CBXC-1492) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | CBXC-1492 | Rat | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ0709 | Anti-CXCL11 (CBXC-2317) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-2317 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4130 | Anti-CXCL11 (CBXC-2347) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-2347 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4131 | Anti-CXCL11 (CBXC-1341) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-1341 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4132 | Anti-CXCL11 (CBXC-1492) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | CBXC-1492 | Rat | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4133 | Anti-CXCL11 (CBXC-2317) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-2317 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3048 | Anti-CXCL11 (CBFYC-0196) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-0196 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0323-LX727 | Anti-CXCL11 VHH(X3XH358) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH358 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX728 | Anti-CXCL11 VHH(X3XH359) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH359 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX729 | Anti-CXCL11 VHH(X3XH360) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH360 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX730 | Anti-CXCL11 VHH(X3XH361) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH361 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX731 | Anti-CXCL11 VHH(X3XH362) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH362 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX732 | Anti-CXCL11 VHH(X3XH363) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH363 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX733 | Anti-CXCL11 VHH(X3XH364) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH364 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX734 | Anti-CXCL11 VHH(X3XH365) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH365 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX735 | Anti-CXCL11 VHH(X3XH366) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH366 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX736 | Anti-CXCL11 VHH(X3XH367) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH367 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX737 | Anti-CXCL11 VHH(X3XH368) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH368 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0823-LX33 | Anti-hCXCL11 (E6) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | E6 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION